Plus   Neg

Teva Pharmaceutical Boosts FY19 Outlook - Quick Facts

While reporting financial results for the third quarter on Thursday, Israeli generic medicines producer Teva Pharmaceutical Industries Ltd. (TEVA) raised its earnings and revenue guidance for the full-year 2019.

For fiscal 2019, the company now projects earnings in a range of $2.30 to $2.50 per share on net revenues between $17.2 billion and $17.4 billion.

Previously, the company expected earnings in a range of $2.20 to $2.50 per share on net revenues between $17.0 billion and $17.4 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.38 per share on revenue of $17.18 billion for the year. Analysts' estimates typically exclude special items.

The company also said it remains on track to achieve its two-year restructuring target of a $3 billion spend base reduction.

Kåre Schultz, Teva's President and CEO, said, "Looking ahead, we are committed to driving long-term shareholder value by maximizing profits from existing core businesses, increasing sales of new brands and products, executing our biosimilar/biologics strategy, delivering manufacturing efficiencies, and generating strong free cash flow for debt repayment."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Tesla has been ordered to stop work at the site of its proposed $4-billion Gigafactory in the German state of Brandenburg due to environmental concerns, according to reports. The proposed factory was going to be Tesla's first Gigafactory in Europe and its fourth in the world. On Saturday, a German court reportedly ordered the company to stop cutting down trees on the 300-hectare site. Dairy Farmers of America (DFA) on Tuesday inked an agreement with bankrupt diary company Dean Foods Co. to become the Stalking Horse Bidder, in a court-supervised sale process, to acquire a substantial portion of Dean's assets and business. While filing for bankruptcy in November last year, Dean Foods had said it was in advanced discussions with the farmer-owned Cooperative. Franklin Resources, Inc. (BEN), a global investment management organization operating as Franklin Templeton, agreed Tuesday to acquire Legg Mason, Inc. (LM) for $50.00 per share of common stock in an all-cash transaction of $4.5 billion. Franklin Templeton will also assume approximately $2 billion...
Follow RTT